Rennova Health, Inc. (RNVA) Releases Quarterly Earnings Results

Rennova Health, Inc. (OTCMKTS:RNVA) announced its earnings results on Monday. The company reported ($10.59) earnings per share for the quarter, Bloomberg Earnings reports.

Rennova Health (OTCMKTS:RNVA) traded down $0.01 during trading on Tuesday, hitting $0.13. The company had a trading volume of 572,104 shares, compared to its average volume of 474,591. The company has a current ratio of 0.11, a quick ratio of 0.11 and a debt-to-equity ratio of -0.23. Rennova Health has a 12-month low of $0.11 and a 12-month high of $103.50.

TRADEMARK VIOLATION WARNING: “Rennova Health, Inc. (RNVA) Releases Quarterly Earnings Results” was posted by Week Herald and is the sole property of of Week Herald. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this piece can be accessed at

About Rennova Health

Rennova Health, Inc (Rennova), formerly CollabRx, Inc, is a provider of diagnostics and supportive software solutions to healthcare providers. The Company operates in three segments: clinical laboratory operations, supportive software solutions, and decision support and informatics operations. The Company is a healthcare enterprise that delivers products and services, including laboratory diagnostics, healthcare technology solutions, and revenue cycle management and intends to provide financial services, to medical providers.

Earnings History for Rennova Health (OTCMKTS:RNVA)

Receive News & Ratings for Rennova Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rennova Health Inc. and related companies with's FREE daily email newsletter.

Leave a Reply